Development of cell-penetrating peptide-conjugated antisense oligonucleotides for the treatment of Fascioscapulohumeral Muscular Dystrophy

Project: Research

Project Details

Effective start/end date1/10/1631/10/18


  • Muscular Dystrophy UK: £72,333.00
  • Muscular Dystrophy UK: £71,303.00
  • Muscular Dystrophy UK: £71,342.00

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being